RVMD Revolution Medicines Corp: Multiplikator forward rega marang pendapatan

Tandha merek RevMed (RVMD)

Revolution Medicines (RVMD) possesses colossal market influence due to the creation of unique RAS protein inhibitors. The forward P/S history demonstrates price volatility, with the current metric standing at 188.70. High clinical trial costs are creating a temporary liquidity deficit. However, success in lung and pancreatic cancer therapies will become a powerful driver for business valuation growth.

RVMD Revolution Medicines, Inc.: Rasio kapitalisasi pasar marang pendapatan mangsa ngarep ing interval 04.07.2022 - 16.11.2026

Rincian metrik lan analitis perusahaan Revolution Medicines, Inc. (RVMD)

- rega saiki lan proyeksi nilai saham:
Analisis umum perusahaan:Revolution Medicines Corp RVMD
Produk sing diprodhuksi revmed.com

For oncology biopharmaceutical company Revolution Medicines (RVMD), whose stability depends on the control of raw material supply chains, the forward P/S ratio serves as an indicator of fundamental resilience relative to future revenues. By analyzing the forward P/S chart on the GURU.Markets platform, an investor compares market capitalization with expected revenue, which allows for the timely identification of asset overheating and the balancing of portfolio risks.

Analisis perusahaan pesaing

Multiplikator Forward P/S ONC (BeiGene Oncology)|Multiplikator Forward P/S Halozyme Corp HALO|ascentage.com - Multiplikator Forward P/S|Rega forward marang dodolan CGON (cgoncology.com)|URGN: Multiplikator Forward P/S|Bicara Therapeutics Inc (BCAX) - Multiplikator Forward P/S|Rasio rega marang prakiraan pendapatan personalis.com|Multiplikator forward rega marang pendapatan Erasca Corp (ERAS)|Multiplikator forward rega marang pendapatan DCTH (Delcath)|Rasio kapitalisasi marang dodolan sing dikarepake Y-mAbs Therapeutics, Inc.|Multiplikator Forward P/S AURA (Aura Biosciences Inc)|Rega forward marang dodolan CADL|ARAY: Multiplikator forward rega marang pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake sellaslifesciences.com SLS|ACTU (Actuate Therapeutics, Inc) - Multiplikator forward rega marang pendapatan|Kapitalisasi marang prakiraan pendapatan CTOR|Rasio rega marang prakiraan pendapatan TuHURA Biosciences Inc.|TARA: Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Fate Therapeutics (FATE)|Rasio kapitalisasi marang dodolan sing dikarepake Aadi Bioscience|Rasio rega marang prakiraan pendapatan TScan Therapeutics Inc TCRX|CSBR: Kapitalisasi marang prakiraan pendapatan|XBIT: Multiplikator forward rega marang pendapatan|Rega forward marang dodolan CVM (cel-sci.com)|OSTX: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Radiopharm Theranostics Ltd (RADX)|ARTV (Artiva) - Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan ANL (Adlai Nortye)|Rasio rega marang prakiraan pendapatan Veru Pharma (VERU)|Multiplikator Forward P/S Tempest Tx (TPST)|Rasio rega marang prakiraan pendapatan xiliotx.com XLO|Enochian BioSciences - Rasio rega marang prakiraan pendapatan|Mural Oncology - Multiplikator Forward P/S|KAPA - Multiplikator Forward P/S|OnKure Therapeutics Inc (OKUR) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan CytoMed|Rasio rega marang prakiraan pendapatan curis.com|Multiplikator forward rega marang pendapatan Apollomics, Inc. (APLM)|Multiplikator Forward P/S THAR|Advanced Biomed Corp - Kapitalisasi marang prakiraan pendapatan|Rasio rega marang prakiraan pendapatan Genprex GNPX|Rasio kapitalisasi marang dodolan sing dikarepake Calidi Bio (CLDI)|sunshinebiopharma.com - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep xeneticbio.com|salariuspharma.com (SLRX) - Rasio rega marang prakiraan pendapatan|Purple Biotech Ltd. - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan AON|Multiplikator Forward P/S BeiGene Ltd.|Rasio rega marang prakiraan pendapatan Checkpoint Therapeutics, Inc. (CKPT)|Multiplikator forward rega marang pendapatan Elevation Oncology, Inc. ELEV|Multiplikator Forward P/S ICAD (iCAD Inc.)|IKNA - Multiplikator forward rega marang pendapatan|NTBL: Multiplikator forward rega marang pendapatan|viracta.com (VIRX) - Multiplikator forward rega marang pendapatan|MorphoSys (MOR) - Rasio rega marang prakiraan pendapatan|NAYA Biosciences Corp (NAYA) - Multiplikator Forward P/S|AAPGV (Ascentage) - Multiplikator Forward P/S